You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指低位見承接現僅跌0.2% 比亞迪、李寧、潤啤、藥明生物及碧服升2%至3% 騰訊反覆探頂
美國去年12月工業生產、生產物價及零售銷售跌幅顯超預期,加上有聯儲局官員再發表「鷹派」言論,市場憂慮央行持續加息將導致經濟陷入衰退,美股三大指數昨晚在30隻藍籌全軍覆沒主導全面低收挫1.2%至1.8%,道指續挫613點最傷。美股期貨全面續軟。然而,亞太股市今早(19日)個別發展,其中日經回吐逾1%結束兩連漲。然而,滬指及深成於虎年最後一個交易日反覆升0.1%及0.4%,半日收3,228及11,862。 恆指繼昨天(18日)反覆高收回升百點後,今早曾反覆跌近300點,低見21,383,隨後跌幅曾收窄至僅13點,高見21,664,現報21,637,僅回吐41點或近0.2%,總成交額469.9億元。 藍籌股個別發展,內需股以李寧(02331.HK)及潤啤(00291.HK)表現最好,股價升逾2.5%,報71.7元及61.55元,中升(00881.HK)升1.5%;吉利(00175.HK)及比亞迪(01211.HK)反覆升1.5%至2%,後者跑贏報226元。 四大藍籌內房反覆升1.2%至1.9%,碧桂園(02007.HK)升幅最大報2.7元;碧服(06098.HK)回升3%報19.64元。此外,藥股以藥明生物(02269.HK)表現最好報71.15元,回升2.6%。 然而,美國經濟數據疲弱,出口股創科(00669.HK)曾挫6%低見98元,現跌幅收窄至逾4%。此外,新經濟股以已九連跌美團(03690.HK)、已三連跌京東-SW(09618.HK)、阿里-SW(09988.HK)、小米-W(01810.HK)、百度-SW(09888.HK)及網易-S(09999.HK)跌逾1%至2.5%;但騰訊(00700.HK)低見374.6元獲承接,最高見384元創逾七個月高,現報382.6元,反覆續升0.7%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account